NCT05685797 is a NA clinical trial of Herpes zoszter (acute)with inter vention in Herper Zoster, sponsored by Keimyung University Dongsan Medical Center.

Who is sponsoring NCT05685797?

NCT05685797 is sponsored by Keimyung University Dongsan Medical Center.

What drugs are being tested in NCT05685797?

Interventions in NCT05685797: Herpes zoszter (acute)with inter vention.

What condition does NCT05685797 study?

NCT05685797 studies Herper Zoster.

Is NCT05685797 still recruiting?

NCT05685797 is currently completed. Last updated 25 September 2025.

Last reviewed 2025-09-25 · How we verify

NCT05685797

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biomarker Study in Patients With Herpes Zoster

Completed NA Last updated 25 September 2025

What this trial tests

NA trial testing Herpes zoszter (acute)with inter vention in Herper Zoster in 30 participants. Completed in 30 November 2023.

Timeline

25 January 2023

Primary endpoint
30 October 2023

30 November 2023

Quick facts

Lead sponsor	Keimyung University Dongsan Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	25 January 2023
Primary completion	30 October 2023
Estimated completion	30 November 2023
Sites	1 location across South Korea

Drugs / interventions tested

Herpes zoszter (acute)with inter vention

Conditions studied

Herper Zoster — all drugs for Herper Zoster →

Sponsor

Keimyung University Dongsan Medical Center

Who can join

Adults 20 to 80, any sex, with Herper Zoster. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators performed this study to investigate the expression levels inflammatory cytokine and neurotransmitters (calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), and β-endorphin) in peripheral blood of participants with herpes zoster.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Keimyung University Dongsan Medical Center trials

Trials by the same sponsor.

NCT06963424 — Pain Relief and and Peripheral Perfusion Index During Erector Spinae Block · NA · completed
NCT06471907 — Comparison of Pain Relief and Peripheral Perfusion Index · NA · recruiting
NCT07210073 — Video Education to Improve Blood Pressure Control in Patients With Ischemic Heart Disease and Hypertension (V-EDUCATE) · NA · completed
NCT06149299 — Great Occipital Nerve Block Using Different Approach · NA · unknown
NCT05705362 — Simple Crossover Versus Side Branch Opening in Patients With Non-Left Main Bifurcation Lesion · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05685797 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Keimyung University Dongsan Medical Center
Last refreshed: 25 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05685797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing